Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teijin Pharma Of Japan Expands Home Healthcare Business Overseas

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Teijin Pharma has accelerated expansion of its home medical care business in the U.S., Europe and Korea. In January, the company acquired Buffalo, New York-based Associated Healthcare Systems, and started providing medical devices to treat adult sleep apnea syndrome. In Europe, Teijin plans to enter the oxygen concentrators and sleep apnea syndrome therapy markets and it aims to establish a joint venture with a European pharmaceutical company this summer. In Korea, Teijin established a joint venture that offers oxygen concentrators rental service with a local pharmaceutical company. (Click here for more - Japanese language) "Teijin Pharma Speeds Up Expansion of Home Healthcare To Overseas" - Nikkan Kogyo News (4/23/08)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068325

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel